Influenza vaccine quadrivalent - PT Bio Farma

Drug Profile

Influenza vaccine quadrivalent - PT Bio Farma

Alternative Names: QIV - PT Bio Farma

Latest Information Update: 17 Nov 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator PT Bio Farma
  • Class Influenza virus vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Preclinical Influenza virus infections

Most Recent Events

  • 16 Nov 2017 Preclinical trials in Influenza virus infections (Prevention) in Indonesia (IM)
  • 16 Nov 2017 PT Bio Farma plans a phase II trial for Influenza virus infections (Prevention, In infants, In children, In adolescents, In adults) in Indonesia (NCT03336593)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top